Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding

Author(s):  Rush Steven D, Vernak Charlene, Zhao Fang

Issue:  Jan/Feb 2017 - Volume 21, Number 1
View All Articles in Issue

Page(s):  83-87

A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding Page 1
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding Page 2
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding Page 3
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding Page 4
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding Page 5

Download in electronic PDF format for $75

Abstract:  Dehydroepiandrosterone supplementation is used to treat a variety of conditions. Rapid-dissolving tablets are a relatively novel choice for compounded dehydroepiandrosterone dosage forms. While rapid-dissolving tablets offer ease of administration, there are uncertainties about the physical and chemical stability of the drug and dosage form during preparation and over long-term storage. This study was designed to evaluate the stability of dehydroepiandrosterone rapid-dissolving tablets just after preparation and over six months of storage. The Professional Compounding Centers of America rapid-dissolving tablet mold and base formula were used to prepare 10-mg strength dehydroepiandrosterone rapid-dissolving tablets. The formulation was heated at 100°C to 110°C for 30 minutes, released from the mold, and cooled at room temperature for 30 minutes. The resulting rapid-dissolving tablets were individually packaged in amber blister packs and stored in a stability chamber maintained at 25°C and 60% relative humidity. The stability samples were pulled at pre-determined time points for evaluation, which included visual inspection, tablet weight check, United States Pharmacopeia disintegration test, and stability-indicating high-performance liquid chromatography. The freshly prepared dehydroepiandrosterone rapiddissolving tablets exhibited satisfactory chemical and physical stability. Time 0 samples disintegrated within 40 seconds in water kept at 37°C. The high-performance liquid chromatographic results confirmed that the initial potency was 101.9% of label claim and that there was no chemical degradation from the heating procedure. Over six months of storage, there were no significant changes in visual appearance, physical integrity, or disintegration time for any of the stability samples. The high-performance liquid chromatographic results also indicated that dehydroepiandrosterone rapid-dissolving tablets retained >95% label claim with no detectable degradation products. The dehydroepiandrosterone rapid-dissolving tablets investigated in this pilot study were physically and chemically stable during preparation and over six months of storage at 25°C and 60% relative humidity.

Related Keywords: Steven D. Rush, PharmD, Charlene Vernak, RPh, Fang Zhao, PhD, dehydroepiandrosterone, DHEA, rapid-dissolving tablets, hormone, steroid, neurosteroid, sexual dysfunction, cognitive decline, osteoporosis, infertility, formulation, stability

Related Categories: FORMULATIONS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, DOSAGE FORMS/DRUG CARRIERS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, STORAGE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding
Rush Steven D
, Vernak Charlene, Zhao Fang
Jan/Feb 2017
Pg. 83-87

Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets
Cheung Matthew
, Zhao Fang, Dave Vivek S
Jan/Feb 2021
Pg. 82-87

Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets
Sayre Casey L
, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap
Jan/Feb 2019
Pg. 62-64

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Homatropine 3-mg Rapid Dissolving Tablets
Allen Loyd V Jr
Mar/Apr 2005
Pg. 151

Quality Control: Rapid Sterility Testing for Compounding Pharmacies
Taylor Andrew
Jul/Aug 2020
Pg. 299-303

The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women
Bramwell Bethany L
Nov/Dec 2010
Pg. 465-471

Aripiprazole 10-mg Oral Dissolving Tablets
Allen Loyd V Jr
Jan/Feb 2016
Pg. 49

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

An Alternative Approach to Tablet Splitting and Grinding for Medication Administration
Taneja Rajneesh
, Scarim Joseph, Pande Poonam G, Scarim Anthony, Nahata Milap C, Jew Rita K, Inabathina Koteswara Rao
May/Jun 2023
Pg. 240-249

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant
Jha Antesh Kr
, Chetia D
Nov/Dec 2011
Pg. 521-525

Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets
Mahesparan Vishnu A/L
, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai
Mar/Apr 2020
Pg. 148-155

Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches
Allen Loyd V Jr
Sep/Oct 2001
Pg. 381

Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches
Allen Loyd V Jr
Jan/Feb 2024
Pg. 65

Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets
Liew Kai Bin
, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
May/Jun 2022
Pg. 255-263

Recent Formulation Advances and Preparation of Orally Disintegrating Tablets
Ejeta Fikadu
Sep/Oct 2022
Pg. 370-377

The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
May/Jun 2010
Pg. 193-199

Molding as Innovative Technology for Personalized Tablet Production
Mady Omar Y
, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
Mar/Apr 2022
Pg. 163-174

Return to Top